We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Extramedullary disease in multiple myeloma in the era of novel agents.
- Authors
Bladé, Joan; Fernández de Larrea, Carlos; Rosiñol, Laura
- Abstract
The author reflects on extramedullary disease (EMD) in patient with multiple myeloma (MM) in the period of novel agents. Topics discussed include the mechanism of the spread of EMD, the association between the addition of lenalidomide to bortezomib-based regimens and the development of EMD, and CD44 antigen and C-X-C chemokine receptor type 4 (CXCR-4) might establish biological markers for EMD development.
- Subjects
MULTIPLE myeloma; BORTEZOMIB; CD44 antigen; CHEMOKINE receptors; BIOMARKERS; PATIENTS
- Publication
British Journal of Haematology, 2015, Vol 169, Issue 6, p763
- ISSN
0007-1048
- Publication type
Editorial
- DOI
10.1111/bjh.13384